Search - Prime Therapeutics

388 Results for GLP-1 Pipeline Update

Quarterly Drug Pipeline: April 2025

Cover image for Quarterly Drug Pipeline: April 2025 Clinical insights and competitive intelligence on anticipated drugs in development Prime Therapeutics /quarterly-drug-pipeline-april-2025 Prime...

Prime Article: Research & Publications PA Research & Publications: Quarterly Drug Pipeline
Managed Healthcare Executive: Prime Therapeutics Finds No Medical Cost Offsets for GLP-1 Obesity Drugs | AMCP Annual 2025

Managed Healthcare Executive: A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member,...

PA Sub-Categories: GLP-1 Prime Article: In the News
AMCP 2024: Behind the GLP-1 Spotlight Session with Ben Urick

Urick, senior principal health outcomes researcher, shares more about his Spotlight Session at the Academy of Managed Care Pharmacy (AMCP)’s Annual Meeting

PA Sub-Categories: GLP-1 Prime Article: Stories
LISTEN NOW: Get the Skinny on GLP-1s: Part 2 — Pharmacy Friends podcast

In this second of a two-part episode of the Pharmacy Friends podcast, industry experts discuss clinical evidence, drug information and appropriate patient selection for GLP-1 use

PA Sub-Categories: GLP-1 Prime Article: Stories